2seventy bio
Justin Conway currently serves as the Program Management and Operations/Continuous Improvement Lead at 2seventy bio, focusing on overseeing manufacturing programs in a Phase 1 facility and leading a Continuous Improvement Team to enhance processes company-wide. Prior to this role, Justin held positions such as Associate Director, Program and Alliance Management at Werewolf Therapeutics, where responsibilities included managing timelines and external collaborations for cancer therapy programs, and CMC Project Manager at PlateletBio. Justin's extensive experience includes key roles in project management and development at Vertex Pharmaceuticals, Anokion, and BIND Therapeutics, as well as a solid foundation in polymer chemistry and product development. Education includes a B.S. and M.S. in Chemistry from Clark University.
2seventy bio
1 followers
2seventy bio is an immuno-oncology cell therapy company that discovers and develops therapies used for cancer treatment.